Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral histories document community mobilisation to participate in decision-making regarding a hazardous waste thermal treatment facility.

Local environment·2024

Same author

Limitations of T2*-Gradient Recalled-Echo and Susceptibility-Weighted Imaging in Characterizing Chronic Subdural Hemorrhage in Infant Survivors of Abusive Head Trauma.

AJNR. American journal of neuroradiology·2016

Same author

Carotid body size on CTA: correlation with comorbidities.

Clinical radiology·2013

Same author

Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.

Acta neurologica Scandinavica·2013

Same author

Non-interventional surveillance study of adverse events in patients with epilepsy.

Acta neurologica Scandinavica·2010

Same author

The provision of cardiology services in a non-cardiac paediatric intensive care unit setting.

Archives of disease in childhood·2010

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Patient satisfaction with an injection device for multiple sclerosis treatment.

J A Cramer¹, B J Cuffel, V Divan

¹Department of Psychiatry, Yale University, New Haven, CT 06516-2770, USA. joyce.cramer@yale.edu

Acta Neurologica Scandinavica

|January 31, 2006

Summary

New injection devices for interferon-beta-1a (IFN-beta-1a) significantly improved patient satisfaction and reduced pain in multiple sclerosis (MS) treatment. Technologically advanced devices offer meaningful benefits for patients.

More Related Videos

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Experiment Videos

Last Updated: Jul 19, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Area of Science:

Neurology
Pharmacology
Medical Devices

Background:

Multiple sclerosis (MS) treatment often involves self-injection with interferon-beta-1a (IFN-beta-1a).
Patient satisfaction and pain are critical factors influencing treatment adherence and quality of life.

Purpose of the Study:

To develop and validate the MS Treatment Concerns Questionnaire (MSTCQ) for assessing treatment satisfaction specific to IFN-beta-1a injections.
To evaluate the impact of a new injection device on patient-reported pain and treatment satisfaction.

Main Methods:

The MSTCQ was developed and administered to patients switching from the Rebiject to the Rebiject II injection device.
Pain assessments were conducted before and 3 months after the device change.

Main Results:

The new device significantly improved MSTCQ scores for Injection System Satisfaction and Side Effects (except Flu-Like Symptoms).
Statistically significant reductions in pain were observed post-device change (P < 0.0001).
Effect sizes indicated clinically meaningful improvements in most measured scales.

Conclusions:

Technologically advanced injection devices can lead to significant improvements in patient satisfaction and pain management for MS patients.
The MSTCQ is a valuable tool for assessing patient concerns related to IFN-beta-1a injection therapy.